Relay for Life: Morai Logistics Marches in Support of Cancer Research & Development

Morai-Logistics-Blog-relay-for-life

Morai Logistics raises $22,420 in support of cancer research and development by marching with members of the community at the 2018 Relay for Life.

Cancer remains one of the leading causes of death in North America. Last year alone, there were 206, 200 new cancer diagnoses in Canada. Furthermore, by the end of 2018 the number of estimated new cases in the United States will be 1,735,350‘. These figures reflect the urgent need for communities, industries and governments to support cancer research and development.

On Friday, June 8th, 2018, Morai Logistics participated in Relay for Life, an annual fundraising event founded by the Canadian Cancer Society. Alongside thousands of members of the community, our team marched together to help ‘fight back against cancer’. These initiatives are a constant pillar of strength to many. However, the urgency to implement processes that effectively facilitate the preventative treatment of cancer remains.

Relay for Life 2

Arthur-Gay: Valued Morai Logistics Team Member. Cancer Survivor.

Forbes identifies patient personalization as a step toward providing optimal customer experience to patients in need of immediate and tailored medical treatment. This phenomena is growing in popularity on both the patient/customer and facility side. By 2022, it’s expected that the personal medicine market will reach USD 2.45 trillion. This will place an increase in pressure on the healthcare supply chain management industry.

This article investigates the importance of personalized medication in improving cancer treatment. It also touches on the role supply chains have in meeting the demands of this growing market.

Personalizing Cancer Treatment

The Canadian Cancer Society defines personalized medicine as the ‘use of information about a person to prevent, diagnose and treat disease’. The ability for medical professionals to determine appropriate and preventative treatment for each individual patient is a product of extensive R&D. It also helps to answer the following six benefits:

  • How likely will an individual develop cancer?
  • Who will benefit from ‘earlier screening’?
  • Which treatment would be effective, while causing less side effects?
  • What appropriate plans should be implemented to manage treatment?
  • How do research develop new treatments?
  • How do we educate patients on making the right ‘treatment decisions’?

This advanced method of understanding and identifying appropriate treatment protocol has shown a considerable advantage in preventing specific cancers. Therefore, it’s important to recognize the impact this growing market will have on healthcare supply chain management.

Challenges in Healthcare Supply Chain Management

Research predicts that the healthcare supply chain management market will reach USD 2.56 billion by 2025. As this treatment approach moves from ‘reaction to prevention’, this will enable medical professionals to offer effective treatment options’. However, research has identified the popularity of personalized medicine will place considerable pressure on manufacturers in supply chains.

Due to the complexities of this individualized approach, challenges in the supply chain manifest in an inability to match ‘scale, speed, reliability and traceability’. Supply Chain Diver indicates that this direct-to-customer approach will require:

  • Increased delivery demand
  • Specific packaging
  • ‘Increased temperature monitoring’
  • Custom clearance in transport
  • Delay monitoring by GPS-based alerts

In addition, the transportation of medication is ‘time and temperature’ sensitive, which places a critical importance on ensuring ‘cold chain is virtually error-free’. When multiple medications are shipped together but require different temperatures, certain challenges may arise. The facilitation of personalized medication creates an intricate shipment lifecycle going from manufacturer to production facility to the patient. However, research also explains that the same third party logistics providers (3PL) run throughout the entire service. For logistics companies, this means recognizing their vital role in facilitating the personalized medication market.

Community of Change

Morai Logistics is passionately dedicated to supporting cancer research and development. As a North American leader in supply chain and logistics, we understand the important role 3PLs play as a partner and advocate for the safe and efficient transport of personalized medication. Our participation in community events, such as Relay for Life, is one of the many ways our company stands with those affected by cancer.  Together, our energetic and passionate team raised $22,420 this year in honour of an incredible cause!

Relay for Life

The Morai Logistics Team at Relay for Life

Leave a Comment

Your email address will not be published. Required fields are marked *